June 17, 2021
1 min read
Save
DARE-19
Issue: June 2021
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Efficacy of dapagliflozin (Farxiga, AstraZeneca) in patients with cardiometabolic risk factors hospitalized with COVID-19.